Alexandria Real Estate Equities
ARE
#2258
Rank
$7.97 B
Marketcap
$46.04
Share price
-4.10%
Change (1 day)
-50.27%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -$1 Billion USD

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are $2.94 Billion USD. a decrease over its 2024 earnings that were of $0.69 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -$1 Billion-242.13%
2024 $0.69 B96.11%
2023 $0.35 B-53.56%
2022 $0.76 B-3.96%
2021 $0.79 B-20.26%
2020 $0.99 B72.88%
2019 $0.57 B3.11%
2018 $0.56 B73.54%
2017 $0.32 B464.88%
2016 $57.15 M-77.32%
2015 $0.25 B36.31%
2014 $0.18 B-10.81%
2013 $0.20 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$10.19 B-1,129.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$25.73 B-2,699.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$8.97 B-1,006.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$9.79 B-1,089.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$1.18 B-219.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$9.32 B-1,042.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$0.57 B-158.16%๐Ÿ‡บ๐Ÿ‡ธ USA